Hamid Mohaghegh Shalmani
Overview
Explore the profile of Hamid Mohaghegh Shalmani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Safdari R, Maserat E, Aghdaei H, Javan Amoli A, Mohaghegh Shalmani H
Gastroenterol Hepatol Bed Bench
. 2017 Mar;
10(1):60-65.
PMID: 28331566
Aim: To survey person centered survival rate in population based screening program by an intelligent clinical decision support system. Background: Colorectal cancer is the most common malignancy and major cause...
12.
Ehsani Ardakani M, Safaei A, Arefi Oskouie A, Haghparast H, Haghazali M, Mohaghegh Shalmani H, et al.
Gastroenterol Hepatol Bed Bench
. 2017 Feb;
9(Suppl1):S14-S22.
PMID: 28224023
Aim: In the current study, we analysised only the articles that investigate serum proteome profile of cirrhosis patients or HCC patients versus healthy controls. Background: Increased understanding of cancer biology...
13.
Noori A, Rahimzadeh S, Shahbazi M, Moradi G, Moghaddam S, Naderimagham S, et al.
Arch Iran Med
. 2016 May;
19(5):329-34.
PMID: 27179164
Objectives: To evaluate the HIV/AIDS burden in Iran from 1980 to 2010 using the Global Burden of Disease Study 2010 (GBD 2010). Methods: The burden of HIV/AIDS in Iran was...
14.
Mohaghegh Shalmani H, Noori A, Shokoohi M, Khajavi A, Darvishi M, Delavari A, et al.
Arch Iran Med
. 2015 Aug;
18(8):508-14.
PMID: 26265519
Background: Hepatitis C virus (HCV) is the foremost cause of deaths attributable to cirrhosis and hepatocellular carcinoma. The Global Burden of Disease study 2010 (GBD 2010) quantifies and compares the...
15.
Ehsani-Ardakani M, Sedaghat M, Eslami G, Mohaghegh Shalmani H
Gastroenterol Hepatol Bed Bench
. 2015 Jul;
8(Suppl 1):S54-9.
PMID: 26171138
Aim: The aim of this study was to evaluate the Helicobacter pylori eradication in the group receiving standard -dose twice a day for two weeks and continue taking amoxicillin for...
16.
Abdolsamadi H, Eini P, Ronasi N, Kaboli S, Hajilooei M, Moghimbeigi A, et al.
Gastroenterol Hepatol Bed Bench
. 2014 May;
6(Suppl 1):S105-11.
PMID: 24834278
Aim: The aim of this study was to determine the concentration of salivary B2M as a marker of viral proliferation in HBS Ag(+), HBV DNA PCR(+) and Hbs Ag(+) and...
17.
Ehsani Ardakani M, Zare E, Basiri M, Mohaghegh Shalmani H
Gastroenterol Hepatol Bed Bench
. 2014 May;
6(4):195-201.
PMID: 24834272
Aim: To evaluate the efficacy of erythromycin to decrease the time and improves the quality of EGD in patients with acute upper GI bleeding. Background: The diagnostic and therapeutic value...
18.
Chorami M, Zojaji H, Naderi N, Moghimi-Dehkordi B, Mirsattari D, Mohaghegh Shalmani H
Gastroenterol Hepatol Bed Bench
. 2014 May;
6(3):141-5.
PMID: 24834261
Aim: This study aimed to evaluate the success of H.pylori eradication therapy in patients with dyspepsia by therapeutics regimes with and without clidinium C. Background: Helicobacter pylori infections are reported...
19.
Nazemalhosseini Mojarad E, Azimirad M, Bayat M, Hellaly A, Aghdaei H, Mohaghegh Shalmani H
Gastroenterol Hepatol Bed Bench
. 2014 May;
5(4):202-8.
PMID: 24834227
Aim: In this study, genetic polymorphism of two tRNA-liked short tandem repeat (STR)-containing loci, R-R and S-Q, was analyzed in order to clarify further the genotypic differences among E. dispar...
20.
Alavi Moghaddam M, Rostami Nejad M, Mohaghegh Shalmani H, Rostami K, Nazemalhosseini Mojarad E, Aldulaimi D, et al.
Int J Prev Med
. 2013 Aug;
4(6):700-4.
PMID: 23930188
Background: Celiac disease (CD) is an immune mediated condition that leads to small bowel atrophy and improve with a gluten free diet (GFD). Extra-intestinal manifestations of CD include hypertransaminasemia. In...